News About: Pharm. Industry
Nicostop dominates local anti-smoking therapy marketHandok Pharm's Nicostop clinched the top position on the local nicotine replacement therapy market, recording its sales of 7.1 billion won in the first half of this year.
Nic...
|
Anti-hangover product 'ionic wave' to debut early next month
A leading local health food maker is planning to begin selling its hangover prevention product 'ionic wave' early next month as the industry is responding with more and more brands to match consumers' needs.
We're ...
Merck completes merger of Serono in Korea
Merck KGaA said on September 17 that it has completed its acquisition procedures of Serono Korea to create a combined pharmaceutical unit between two companies.
In September 2006, Merck KGaA announced its intent to...
Bayer HealthCare to storm birth control market
The domestic sales of Bayer HealthCare's birth control products grew 13 percent last year, driven by the strength of Myvlar, Minivlar and Postinor-1. But Bayer HealthCare is not stagnating.
Approved by the Korea Fo...
Long-term alliance with partners is key to globalization
Korean pharmaceutical companies need to establish their long-term with foreign partners if they wants to pursue its goal of embracing globalization, said a company official.
In the era of globalization, Korean drug...
Anti-cervical cancer vaccine released from September 12
MSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., said that Korean women can be vaccinated with an anti-cervical cancer vaccine, dubbed Gardasil, from September 12.
On July 27, 2007, the Korea ...
Pharmaceutical firms all-out to boost OTC sales
Local drug makers have seen robust growth in earnings for the past couple of years on strong demand for ethical drugs. However, they are finding it increasingly difficult to boost their bottom line amid prolonged busi...
MSD to make partnership with Korean firms on enhanced intellectual property right
"Partnering with the continuous flow of external innovations based on higher recognition of intellectual property right is central to the success of our research and development efforts, said Bharat Chowrira, licensin...
New Oral Contraceptive Yasmin to release next month
The world's leading oral contraceptive Yasmin will go on sale in Korea from October 1, according to Bayel Healthcare.
Yasmin, a combined oral contraceptive, is available in a 21-pill package and was approved by the...
Dongwha to promote OTC marketing
Dongwha Pharm said on September 12 that it would step up its OTC marketing of Helmin 200 soft cap. (arginine tidiacicate), liver protector and Isetax (chamomile tinc), mouth refresher, as part of its efforts to captur...
